Fever medicine comforts a sick baby but does not shorten the illness or prevent a seizure

A fever is the body's thermostat, turned up

A fever is not the illness. It is the body raising its own set point on purpose, a regulated response to infection rather than a fault in temperature control. The American Academy of Pediatrics states it plainly: fever "is not an illness but is, in fact, a physiologic mechanism that has beneficial effects in fighting infection."¹ Two facts follow that a worried parent rarely holds together. The height of the fever does not track how sick the child is, because "the degree of fever does not always correlate with the severity of illness."¹ And bringing the number down does not, on its own, make the illness milder or shorter. There is "no evidence that reducing fever reduces morbidity or mortality from a febrile illness."¹

That reframes what the bottle on the shelf is for. The stated goal of acetaminophen or ibuprofen "is not simply to normalize body temperature but to improve the overall comfort and well-being of the child."¹ Britain's National Institute for Health and Care Excellence gives the same instruction from the other side: "do not use antipyretic agents with the sole aim of reducing body temperature."² The thermometer reading measures how hard the defense is working. It says little about how much danger the child is in.

This lands in a particular month. Around six months, ibuprofen becomes a labeled option beside acetaminophen,³ so a household that had one fever medicine now has two, and the same questions attach to both.

What acetaminophen and ibuprofen actually do

The benefit the evidence supports is comfort, and comfort is not nothing. A baby who is miserable, off her feed, and not sleeping because of a fever often becomes easier in herself and easier to feed once the fever eases. Both drugs work on a similar timetable. At standard weight-based doses, acetaminophen at 10 to 15 mg/kg every four to six hours and ibuprofen at 10 mg/kg, most children are cooler within about 30 to 60 minutes, and roughly 80% respond inside that window.¹

The choice between the two is where the six-month mark earns its place. Acetaminophen is used across infancy. Ibuprofen's over-the-counter label gives no dose below six months and tells the parent of a younger infant to "ask a doctor,"³ and the AAP notes the same gap: the data "are inadequate to support a specific recommendation for the use of ibuprofen ... in infants younger than 6 months."¹ So the practical change at this age is small and specific. A second comfort medicine becomes available, on the same logic as the first.

What neither drug changes is what a parent most wants changed: how sick the child is, and how long it lasts.

Whether treating the fever shortens the illness

The folk belief cuts both ways. Some parents dose at the first warm forehead, hoping to shorten the cold. Others hold off, on the theory that a fever left alone burns the illness out faster. The trials support neither.

A 2013 systematic review by Purssell and While pooled the studies that timed how long fever lasted with and without antipyretics. Across five trials, fever cleared about four hours sooner with the medicine, not later (pooled mean difference −4.16 hours, 95% CI −6.35 to −1.96).⁴ So the "let it burn" theory runs backwards: suppressing the fever did not prolong anything the studies could measure. But the same result deflates the opposite hope. Four hours is thermometer time, not a shorter cold, and three of the five pooled trials were of malaria rather than the everyday viral fevers a baby at home has.⁴ The honest reading is that antipyretics neither meaningfully lengthen nor shorten the illness.

This sits against a hedge in the AAP's own report, which notes that "limited data have revealed that fever actually helps the body recover more quickly from viral infections."¹ A parent could read that as a reason to let a fever run. The evidence does not carry that far. A possible role for fever in recovery is not a measured penalty for treating it, and the duration data show no such penalty. What the two together support is modest: treat for comfort, and expect the illness to run about the course it would have run anyway.

Antipyretics do not prevent a febrile seizure

The fear that drives a great deal of fever dosing is the febrile seizure: the sudden, whole-body convulsion that a high fever can trigger in a young child. It is common enough to be a real worry. Between 2 and 5 of every 100 children aged six months to five years have at least one.⁵ Most are brief and leave no harm, but no parent who has seen one forgets it, and the intuition that keeping the fever low keeps the seizure away is nearly universal.

That intuition is wrong. A child who has had one febrile seizure is prone to another: after a first simple febrile seizure, roughly half of children under a year, and roughly a third of those older, have a recurrence.⁵ The question a parent asks is whether steady dosing with a fever medicine lowers that chance. A randomized trial by Strengell and colleagues tested exactly that, following 231 Finnish children for two years and giving some an antipyretic at every fever and others a placebo. Of the children given the medicine, 46 of 197 (23%) had another seizure; of those given the placebo, 8 of 34 (24%) did.⁶ The medicine moved the recurrence rate by less than one child in a hundred.

That single trial is a thin reed to hang a counterintuitive result on. Its two arms were badly unbalanced, 197 children on the medicine against 34 on placebo, so the placebo group is small and the confidence interval around the near-zero difference is wide (95% CI −12.8 to +17.6 percentage points).⁶ What lets the finding stand is not this one study but the agreement of the guidelines that read the whole literature.

Combining both drugs lowers the temperature without lowering the distress

When one medicine does not seem to be working, the obvious next move is to use both, or to alternate them. On the thermometer, this works. A Cochrane review of six trials in 915 children found that giving acetaminophen and ibuprofen together produced a lower average temperature at four hours, about 0.7°C below either drug alone, and that alternating them lowered the temperature about 0.6°C more roughly an hour after the second dose.⁷ The PITCH trial found the same shape in the first four hours: combined therapy bought about 55 more minutes without fever than acetaminophen alone.⁸

But the same PITCH trial looked for a matching gain in the child's comfort and other symptoms and found none: "no benefit was found for discomfort or other symptoms," though the trial was underpowered to detect a small one.⁸ The extra fraction of a degree came off the thermometer without a matching change in how the child felt. And the second drug adds a real hazard. Combination regimens "may place infants and children at increased risk because of dosing errors," a concern grounded in how often parents mismeasure: about half give an incorrect dose, and roughly 15 in 100 give too much.¹

That is why the guidelines decline to endorse routine combining even as the trials confirm the temperature effect. The AAP finds "insufficient evidence to support or refute" it and stresses the error risk.¹ NICE is more directive, instructing parents to "not give both agents simultaneously" and to consider alternating only "if the distress persists."² The disagreement is not really about the thermometer, on which the two sides agree. It is about the endpoint. The trials measured a number the guidelines have already called the wrong target.

Where a fever stops being a home matter

Everything so far assumes a well baby past the youngest weeks, where comfort is the reasonable goal and the thermometer is a poor guide to worry. There is one place that logic reverses, and it is a hard line rather than a judgment call.

For the youngest infants, a fever is a medical matter regardless of how well the baby looks. The AAP's guideline for well-appearing febrile infants and NICE agree on the number: a rectal temperature of 38.0°C (100.4°F) or higher.⁹² Below the number, appearance can reassure. At or above it in a young enough infant, appearance cannot, because the risk of a serious bacterial infection is real and falls steeply with each week of age. In one cohort of 4,778 febrile infants, bacteria in the blood were found in 5.3% at two weeks of age, 3.3% at three weeks, and 1.6% at four.⁹ That decline is why the strictest rules apply to the newborn weeks.

The rule softens across the months this baby is now in, but it changes category rather than disappearing. NICE places any infant under three months with a temperature of 38.0°C or higher in its highest-risk group, and moves a three-to-six-month-old to an intermediate-risk group at 39°C or higher.² The number that triggers concern rises and the response shifts from emergency toward prompt assessment, but the comfort-first logic that governs an older child does not yet fully apply to one this young. There is no single new bright line at six months, only a graded loosening of a strict one. At any age, some signs override the thermometer entirely.

For a baby past the newborn weeks who is feeding, responsive, and settled between fevers, the evidence changes the home routine less than it changes the reason for it. The medicine is still worth giving, but for how the baby feels rather than for the number. There is no reason to chase a normal reading, to run two drugs at once, or to dose around the clock against a seizure the medicine cannot prevent. A rectal temperature of 38.0°C in a young infant, or any red sign at any age, is not a fever to manage from the medicine cabinet. It is a call to a clinician, or to emergency care.